Stemline Therapeutics, Inc.
(NASDAQ : STML)

( )
STML After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.36%80.240.9%$594.15m
CELGCelgene Corporation
1.57%138.861.1%$558.43m
AMGNAmgen Inc.
2.36%186.191.1%$449.83m
BIIBBiogen Inc.
2.62%344.471.2%$386.48m
REGNRegeneron Pharmaceuticals, Inc.
-0.70%442.562.7%$317.95m
ALNYAlnylam Pharmaceuticals, Inc
-2.61%118.7010.7%$256.31m
VRTXVertex Pharmaceuticals Incorporated
0.23%155.051.9%$221.45m
INCYIncyte Corporation
-0.82%115.642.5%$207.97m
ALXNAlexion Pharmaceuticals, Inc.
1.65%143.161.9%$182.04m
ILMNIllumina, Inc.
0.12%206.483.5%$139.87m
EXELExelixis, Inc.
-2.48%28.306.5%$135.44m
CLVSClovis Oncology, Inc.
-3.85%81.3216.5%$124.68m
BLUEBluebird Bio, Inc.
-2.16%140.2017.3%$118.12m
SRPTSarepta Therapeutics, Inc.
1.95%51.7216.9%$110.02m
BMRNBioMarin Pharmaceutical Inc.
-1.18%93.544.4%$103.49m

Company Profile

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. It develops a discovery platform called StemScreen, which identifies novel compounds that target and kill cancer stem cells. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.